Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Authors

• A J Armstrong
• E S Antonarakis
• M-E Taplin
• W K Kelly
• H Beltran
• K Fizazi
• W L Dahut
• N Shore
• S Slovin
• D George
• M A Carducci
• P Corn
• D Danila
• R Dreicer
• E Heath
• D Rathkopf
• G Liu
• D Nanus
• M Stein
• M R Smith
• C Sternberg
• G Wilding
• P S Nelson
• S Halabi
• P Kantoff
• N W Clarke
• C P Evans
• A Heidenreich
• N Mottet
• M Gleave
• M J Morris
• H I Scher

Publication/Presentation Date

1-1-2018

Volume

29

Issue

1

First Page

23

Last Page

25

ISSN

1569-8041

Published In/Presented At

Armstrong, A. J., Antonarakis, E. S., Taplin, M. E., Kelly, W. K., Beltran, H., Fizazi, K., Dahut, W. L., Shore, N., Slovin, S., George, D., Carducci, M. A., Corn, P., Danila, D., Dreicer, R., Heath, E., Rathkopf, D., Liu, G., Nanus, D., Stein, M., Smith, M. R., … Scher, H. I. (2018). Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. Annals of oncology : official journal of the European Society for Medical Oncology, 29(1), 23–25. https://doi.org/10.1093/annonc/mdx648

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

29088323

Department(s)

Administration and Leadership

Document Type

Article